EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patients

Benedict Fallet, Mathilde Foglierini, Raphael Porret, Ana Alcaraz-Serna, Christophe Sauvage, Raphael Jenelten, Teofila Caplanusi, Michel Gilliet, Laurent Perez, Craig Fenwick, Raphael Genolet, Alexandre Harari und 4 weitere

Journal of Infection · 2023

DOI: 10.1016/j.jinf.2023.06.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Infection, 2023. Verfasst von Benedict Fallet und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology and Allergy, University Hospital of Lausanne, Switzerland. Hauptthemen laut MEDLINE: T-Lymphocytes, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Intradermal skin test (IDT) with mRNA vaccines may represent a simple, reliable, and affordable tool to measure T cell response in immunocompromised patients who failed to mount serological responses following vaccination with mRNA covid-19 vaccines. METHODS: We compared anti-SARS-CoV-2 antibodies and cellular responses in vaccinated immunocompromised patients (n = 58), healthy seronegative naive controls (NC, n = 8), and healthy seropositive vaccinated controls (VC, n = 32) by Luminex, spike-induced IFN-γ Elispot and an IDT. A skin biopsy 24 h after IDT and single-cell RNAseq was performed in three vaccinated volunteers. RESULTS: Twenty-five percent of seronegative NC had a positive Elispot (2/8) and IDT (1/4), compared to 95% (20/21) and 93% (28/30) in seropositive VC, respectively. Single-cell RNAseq data in the skin of VC showed a predominant mixed population of effector helper and cytotoxic T cells. The TCR repertoire revealed 18/1064 clonotypes with known specificities against SARS-CoV-2, among which six were spike-specific. Seronegative immunocompromised patients with positive Elispot and IDT were in 83% (5/6) treated with B cell-depleting reagents, while those with negative IDT were all transplant recipients. CONCLUSIONS: Our results indicate that delayed local reaction to IDT reflects vaccine-induced T-cell immunity opening new perspectives to monitor seronegative patients and elderly populations with waning immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-LymphocytesCOVID-19AgedHumansCOVID-19 VaccinesSARS-CoV-2BiomarkersmRNA VaccinesAntibodies, ViralImmunocompromised HostSkin TestsVaccination

Stichwörter der Autor:innen

COVIDImmunosuppressionSARS-CoV-2SkinT cellsVaccine

Substanzen

COVID-19 VaccinesBiomarkersmRNA VaccinesAntibodies, Viral

Autor:innen und Institutionen

  • Division of Immunology and Allergy, University Hospital of Lausanne, Switzerland.
  • Division of Immunology and Allergy, University Hospital of Lausanne, Switzerland; Biomedical Data Science Center, University Hospital of Lausanne, Switzerland.
  • Center for Cell Immunotherapy, Department of Oncology and Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne CH-1066, Switzerland.
  • Department of Dermatology and Venereology, University Hospital of Lausanne, Switzerland.
  • Department of Dermatology and Venereology, University Hospital of Lausanne, Switzerland; University of Lausanne, Faculty of Biology and Medicine, Lausanne, Switzerland.
  • Division of Immunology and Allergy, University Hospital of Lausanne, Switzerland; University of Lausanne, Faculty of Biology and Medicine, Lausanne, Switzerland.

Zitieren

APA

Fallet, B., Foglierini, M., Porret, R., Alcaraz-Serna, A., Sauvage, C., Jenelten, R., Caplanusi, T., Gilliet, M., Perez, L., Fenwick, C., Genolet, R., Harari, A., Bobisse, S., Gottardo, R., Pantaleo, G., & Muller, Y. D. (2023). Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patients. Journal of Infection. https://doi.org/10.1016/j.jinf.2023.06.005

Vancouver

Fallet B, Foglierini M, Porret R, Alcaraz-Serna A, Sauvage C, Jenelten R, et al. Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patients. Journal of Infection. 2023. doi:10.1016/j.jinf.2023.06.005

BibTeX
@article{Fallet2023,
  author = {Fallet, Benedict and Foglierini, Mathilde and Porret, Raphael and Alcaraz-Serna, Ana and Sauvage, Christophe and Jenelten, Raphael and Caplanusi, Teofila and Gilliet, Michel and Perez, Laurent and Fenwick, Craig and Genolet, Raphael and Harari, Alexandre and Bobisse, Sara and Gottardo, Raphael and Pantaleo, Giuseppe and Muller, Yannick D},
  title = {Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patients},
  journal = {Journal of Infection},
  year = {2023},
  doi = {10.1016/j.jinf.2023.06.005}
}
Kostenlos starten →